Back to Authors

Hammond, Edward

Mayo Clinic

Progen Pharmaceuticals Ltd, Brisbane, Queensland, Australia

Citations 1

Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine

Oncotarget | September 24, 2019 | Volume: 10 | Issue: 54 | Pages: 5669-5669

10.18632/oncotarget.27216 | PMID 31608142